COOPER GLENN L MD

CIK 00010463514 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001046351

Recent Transactions

48 trades

Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2019-05-23$5.00/sh+24,000→ 64,709 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2019-05-23$66.91/sh−4,734→ 35,975 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2019-05-23$67.53/sh−266→ 35,709 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2019-05-23−24,000→ 0 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2019-05-23$67.53/sh−266→ 59,709 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2019-05-23$66.91/sh−4,734→ 59,975 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2019-05-15+2,109→ 2,109 total
Award
REPLIGEN CORP$RGEN
Common Stock
2019-05-15+923→ 40,709 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2018-05-16+3,304→ 3,304 total
Award
REPLIGEN CORP$RGEN
Common Stock
2018-05-16+1,486→ 39,786 total
Award
REPLIGEN CORP$RGEN
Common Stock
2017-05-18+1,206→ 38,300 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2017-05-18+2,434→ 2,434 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2016-05-11+3,366→ 3,366 total
Award
REPLIGEN CORP$RGEN
Common Stock
2016-05-11+1,763→ 37,094 total
Award
REPLIGEN CORP$RGEN
Common Stock
2015-11-09$26.56/sh+1,000→ 35,331 total
Award
REPLIGEN CORP$RGEN
Common Stock
2015-05-21+1,019→ 34,331 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2015-05-21+1,992→ 1,992 total
Award
REPLIGEN CORP$RGEN
Common Stock
2013-05-09+5,342→ 31,380 total
Purchase
Fortress Biotech, Inc.$FBIO
Common Stock, par value $0.001
2012-11-30$4.02/sh+3,811→ 43,811 total
Purchase
REPLIGEN CORP$RGEN
Common Stock
2012-09-21$6.09/sh+3,000→ 24,038 total
Purchase
REPLIGEN CORP$RGEN
Common Stock
2012-09-21$6.08/sh+2,000→ 26,038 total
Purchase
REPLIGEN CORP$RGEN
Common Stock
2012-09-21$6.09/sh+5,000→ 21,038 total
Purchase
Fortress Biotech, Inc.$FBIO
Common Stock, par value $0.001
2012-06-22$5.30/sh+10,000→ 40,000 total
Award
REPLIGEN CORP$RGEN
Common Stock
2012-05-24+11,038→ 16,038 total
Award
Fortress Biotech, Inc.$FBIO
Options to purchase Common Stock
2012-02-10+45,000→ 45,000 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2011-12-15+15,000→ 59,000 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2010-09-16+20,000→ 44,000 total
Purchase
REPLIGEN CORP$RGEN
Common Stock
2009-11-09$4.98/sh+5,000→ 5,000 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2009-08-24+24,000→ 24,000 total
Disposition from Tender
Endo Pharmaceuticals Solutions Inc.
Common Stock
2009-02-24−279,898→ 0 total
Exercise/Conversion
Endo Pharmaceuticals Solutions Inc.
Common Stock
2009-02-23+279,898→ 279,898 total
Disposition from Tender
Endo Pharmaceuticals Solutions Inc.
Common Stock
2009-02-23−467,091→ 0 total
Exercise/Conversion
Endo Pharmaceuticals Solutions Inc.
Performance Rights
2009-02-23−279,898→ 52,412 total
Award
Endo Pharmaceuticals Solutions Inc.
Stock Option (Right to Buy)
2008-12-04+800,000→ 800,000 total
Award
Endo Pharmaceuticals Solutions Inc.
Stock Option (Right to Buy)
2008-12-04+70,000→ 70,000 total
Disposition to Issuer
Endo Pharmaceuticals Solutions Inc.
Stock Option (Right to Buy)
2008-12-04−70,000→ 0 total
Award
Endo Pharmaceuticals Solutions Inc.
Stock Option (Right to Buy)
2008-12-04+360,000→ 360,000 total
Disposition to Issuer
Endo Pharmaceuticals Solutions Inc.
Stock Option (Right to Buy)
2008-12-04−360,000→ 0 total
Disposition to Issuer
Endo Pharmaceuticals Solutions Inc.
Stock Option (Right to Buy)
2008-12-04−800,000→ 0 total
Award
Endo Pharmaceuticals Solutions Inc.
Stock Option (Right to Buy)
2008-12-04+60,000→ 60,000 total
Disposition to Issuer
Endo Pharmaceuticals Solutions Inc.
Stock Option (Right to Buy)
2008-12-04−60,000→ 0 total
Award
Endo Pharmaceuticals Solutions Inc.
Common Stock
2008-09-25+158,191→ 467,091 total
Award
Endo Pharmaceuticals Solutions Inc.
Performance Rights
2008-09-25+0→ 0 total
Award
Endo Pharmaceuticals Solutions Inc.
Performance Rights
2007-10-30+0→ 0 total
Award
Endo Pharmaceuticals Solutions Inc.
Common Stock
2007-10-30+42,000→ 308,900 total
Purchase
Endo Pharmaceuticals Solutions Inc.
Common Stock, $.001 par value
2006-01-09$5.85/sh+10,000→ 195,000 total
Purchase
Endo Pharmaceuticals Solutions Inc.
Common Stock, $.001 par value
2005-02-15$4.05/sh+10,000→ 185,000 total
Award
GENTA INC DE/
Non-Employee Directors' 1998 Stock Option Plan Options
1999-07-13−50,000→ 387,500 total

Companies

Recent Filings

Address

INDEVUS PHARMACEUTICALS, INC. 33 HAYDEN AVENUE

LEXINGTON, MA, 02421

View on SEC.gov